OPRD1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA14558-Each-of-1 | In Stock | ₹ 46,502.50 |
PA14558 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
OPRD1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
OPRD1
Gene Alias
delta 1 opioid receptor; delta opioid receptor 1; delta-type opioid receptor; DOR; D-OR-1; DOR-1; K56; mDOR; MSL-2; Nbor; Opioid receptor; opioid receptor A; opioid receptor delta 1; opioid receptor, delta 1; OPRD; Oprd1; Ror-a
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
18386, 24613, 4985
Content And Storage
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Gene Accession No.
P32300, P33533, P41143
Gene Symbols
OPRD1
Immunogen
Synthetic peptide corresponding to residues L(3) V P S A R A E L Q S S P L V(17) of mouse and rat DOR-1.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-4558 detects delta Opioid Receptor from human, mouse, and rat samples
- PA1-4558 has been successfully used in Western blotting applications
- This antibody will detect a dominant band of ∽48 kDa representing the monomer form of DOR-1, and may also detect dimmers or trimers as heterodimerization and homodimerization is common The PA1-4558 immunogen is a synthetic peptide corresponding to residues 3-17 L(3) V P S A R A E L Q S S P L V(17) of mouse and rat DOR-1
- OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain
- It is a promising target in the therapy of mood-altering disorders and drug addiction
- Delta and kappa opioid receptors function synergistically by forming heterodimers
- OPRD1 expression has been reported primarily in the brain
- High OPRD1 expression has been documented in the cortex, caudate, hippocampus, nucleus accumbens, and putamen; low OPRD1 expression has been identified in the cerebellum, hypothalamus, substantia nigra, and thalamus
- OPRD1 expression is reduced in the putamen and amygdala of Alzheimer's patients and in the putamen in Parkinson's disease.